October 13, 2025Journal of the International AIDS SocietyOpen Access

Incidence and outcomes of anal and cervical cancer among adults with HIV in Latin America: a retrospective cohort study

View Full Paper

Ask AI

Bookmark

Authors

RPRachael PellegrinoVanderbilt University Medical Center STShengxin TuVanderbilt University Medical Center RBRodrigo BenavidesInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

Discussion

Member takes

Implication

Retrospective cohort analysis finds no decrease in anal and cervical cancer incidence rates in HIV-positive individuals, indicating ongoing prevention needs.

Key Points

The overall incidence of cervical cancer was found to be 62.2 per 100,000 person-years, signaling a notable health concern among women with HIV in Latin America.
Among MSM, the incidence rate for anal cancer was 59.1 per 100,000 person-years, while females and non-MSM males showed significantly lower rates.
Using Cox proportional hazard models, a higher CD4 cell count was associated with a decreased risk of anal cancer.
The projected 5-year survival rates for cervical and anal cancer were 72.6% and 58.5%, respectively, highlighting disparities in outcomes.

Cite This Study

Pellegrino et al. (2025) studied this question.

synapsesocial.com/papers/68ec51e642911f61ef8b24f4 https://doi.org/10.1002/jia2.70050

View Full Paper

Ask AI

Bookmark

Implication

Retrospective cohort analysis finds no decrease in anal and cervical cancer incidence rates in HIV-positive individuals, indicating ongoing prevention needs.

Incidence and outcomes of anal and cervical cancer among adults with HIV in Latin America: a retrospective cohort study

Discussion

Member takes

Implication

Key Points

Cite This Study

Incidence and outcomes of anal and cervical cancer among adults with HIV in Latin America: a retrospective cohort study

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider